Vaxcyte (PCVX) Change in Acquisitions & Divestments (2021 - 2026)

Vaxcyte (PCVX) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $340.6 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 22.32% year-over-year to $340.6 million in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 187.19% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 2186.68% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $340.6 million, down from $348.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for PCVX reached as high as $853.8 million in Q3 2024 and fell as low as -$802.7 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $170.0 million across 5 years, with a median of $83.9 million in 2022.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 13298.57% in 2024 and fell as far as 233.1% in 2024.
• Year by year, Change in Acquisitions & Divestments stood at $158.2 million in 2022, then jumped by 281.24% to $603.1 million in 2023, then plunged by 233.1% to -$802.7 million in 2024, then jumped by 143.35% to $348.0 million in 2025, then declined by 2.11% to $340.6 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $340.6 million in Q1 2026, $348.0 million in Q4 2025, and $350.2 million in Q3 2025.